Angiotensin receptor-neprilysin inhibition in patients with de novo acute decompensated heart failure: a prespecified subgroup analysis of the PIONEER-HF trial
31 August 2019 (00:00 - 00:00)
Organised by:
About the speaker
Kaiser Permanente, San Francisco Medical Centre and Medical Offices, San Francisco (United States of America)
4 More presentations in this session
Access the full session
The Event
ESC Congress 2019
31 August - 4 September 2019
You may be interested in
Congress Presentation
